Interventional Active not recruiting
NCT05129787 on ClinicalTrials.gov
Ablation vs Resection of Colorectal Cancer Liver Metastases
Official title: A Randomized Controlled Trial of Needle Ablation With 3D Verification vs Surgical Resection of Colorectal Cancer Liver Metastases
- Sponsor: Oslo University Hospital
- Enrollment: 230 (Estimated)
- Study start: 2021-12-16 (Actual)
- Primary completion: 2026-10-23 (Estimated)
- Study completion: 2030-10-23 (Estimated)
- Allocation: Randomized
- InterventionModel: Parallel
- Masking: Double (Participant, Care Provider)
- PrimaryPurpose: Treatment
Brief Summary
230 patients with colorectal cancer liver metastases will be randomly assigned to resection or thermal ablation.
Conditions
- Colorectal Cancer Metastatic
Intervention / Treatment
- Procedure: Surgical resection
- Procedure: Thermal ablation
Primary Outcome Measures
-
Local tumor progression
(12 months)
Local tumor progression at site of treatment
Countries
Norway
Locations and Investigators
- Oslo University Hospital, Department of Gastrointestinal surgery, The National Hospital, Oslo, Norway